| Product Code: ETC7750453 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Japan's import shipments of transdermal scopolamine patches in 2024 were primarily sourced from top exporting countries such as Germany, Switzerland, USA, Italy, and Metropolitan France. Despite the low Herfindahl-Hirschman Index indicating a lack of concentration in the market, the compound annual growth rate (CAGR) from 2020 to 2024 was -5.32%, with a slight improvement as the growth rate from 2023 to 2024 was -3.46%. This data suggests a stable but slightly declining trend in the import market for transdermal scopolamine patches in Japan.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Transdermal Scopolamine Patch Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Transdermal Scopolamine Patch Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Transdermal Scopolamine Patch Market - Industry Life Cycle |
3.4 Japan Transdermal Scopolamine Patch Market - Porter's Five Forces |
3.5 Japan Transdermal Scopolamine Patch Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Japan Transdermal Scopolamine Patch Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Japan Transdermal Scopolamine Patch Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of motion sickness and post-operative nausea and vomiting |
4.2.2 Growing awareness about the benefits of transdermal drug delivery |
4.2.3 Rising geriatric population in Japan |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 Competition from alternative treatments such as oral medications |
4.3.3 Potential side effects associated with transdermal scopolamine patches |
5 Japan Transdermal Scopolamine Patch Market Trends |
6 Japan Transdermal Scopolamine Patch Market, By Types |
6.1 Japan Transdermal Scopolamine Patch Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Transdermal Scopolamine Patch Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Japan Transdermal Scopolamine Patch Market Revenues & Volume, By 1mg, 2021- 2031F |
6.1.4 Japan Transdermal Scopolamine Patch Market Revenues & Volume, By 1.5mg, 2021- 2031F |
6.2 Japan Transdermal Scopolamine Patch Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Japan Transdermal Scopolamine Patch Market Revenues & Volume, By Motion Sickness, 2021- 2031F |
6.2.3 Japan Transdermal Scopolamine Patch Market Revenues & Volume, By Nausea/Vomiting, 2021- 2031F |
6.2.4 Japan Transdermal Scopolamine Patch Market Revenues & Volume, By Parkinsonian Tremor, 2021- 2031F |
6.2.5 Japan Transdermal Scopolamine Patch Market Revenues & Volume, By Others, 2021- 2031F |
7 Japan Transdermal Scopolamine Patch Market Import-Export Trade Statistics |
7.1 Japan Transdermal Scopolamine Patch Market Export to Major Countries |
7.2 Japan Transdermal Scopolamine Patch Market Imports from Major Countries |
8 Japan Transdermal Scopolamine Patch Market Key Performance Indicators |
8.1 Patient adherence rate to transdermal scopolamine patch treatment |
8.2 Number of clinical trials evaluating the efficacy and safety of transdermal scopolamine patches |
8.3 Rate of adoption of transdermal drug delivery technology in the healthcare sector in Japan |
9 Japan Transdermal Scopolamine Patch Market - Opportunity Assessment |
9.1 Japan Transdermal Scopolamine Patch Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Japan Transdermal Scopolamine Patch Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Japan Transdermal Scopolamine Patch Market - Competitive Landscape |
10.1 Japan Transdermal Scopolamine Patch Market Revenue Share, By Companies, 2024 |
10.2 Japan Transdermal Scopolamine Patch Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |